Skip to main content
Premium Trial:

Request an Annual Quote

Exosome Diagnostics, Promega Ink Sample Prep Kit Deal

NEW YORK (GenomeWeb News) – Exosome Diagnostics today said that Promega will be the exclusive supplier of its Urine Clinical Sample Concentrator Kit, which incorporates Exosome's technology for concentration of urinary exosomes.

The kit is sued for molecular diagnostic applications, and New York-based Exosome said that it will be used to process urine samples for clinical trials in genitourinary disorders, such as prostate cancer. Financial and other terms of the agreement weren't disclosed.

"This agreement is another important milestone in the execution of our molecular diagnostics commercial strategy," Exosome Diagnostics CEO James McCullough said in a statement. "We're pleased to be working with Promega, a manufacturer who has decades of experience in coupling the latest scientific advances in molecular biology with excellent cGMP manufacturing capability."

The Scan

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.

Team Presents Cattle Genotype-Tissue Expression Atlas

Using RNA sequences representing thousands of cattle samples, researchers looked at relationships between cattle genotype and tissue expression in Nature Genetics.

Researchers Map Recombination in Khoe-San Population

With whole-genome sequences for dozens of individuals from the Nama population, researchers saw in Genome Biology fine-scale recombination patterns that clustered outside of other populations.

Myotonic Dystrophy Repeat Detected in Family Genome Sequencing Analysis

While sequencing individuals from a multi-generation family, researchers identified a myotonic dystrophy type 2-related short tandem repeat in the European Journal of Human Genetics.